MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » St. Jude invests in leadless pacemaker startup | Deals roundup

St. Jude invests in leadless pacemaker startup | Deals roundup

By

St. Jude Medical, Nanostim

St. Jude Medical Inc. (NYSE:STJ) invested in a startup developing leadless pacemakers.

The St. Paul, Minn.-based cardiac device maker entered a financing deal with Nanostim Inc. through which it intends to make staged investments based on the company’s achievement of certain development and clinical milestones, according to a statement from Nanotism.

The agreement between the two companies also gives St. Jude the exclusive option to acquire the Milpitas, Calif.-based company.

Nanostim is also backed by InterWest Partners, US Venture Partners, Emergent Medical Partners and Life Science Angels.

The company is working on MRI-compatible, "miniaturized," pacemakers which are designed to be placed inside the heart of a cardiac patient in a percutaneous, catheter-based procedure. The devices are leadless, and therefore aren’t connected to the heart muscle via wires, a modification over previous models that the company touts as major safety improvement.

"Our leadless pacemakers are designed to be less invasive, safer devices that will simplify the implantation procedure…" Nanotism CEO Drew Hoffmann said in prepared remarks. "These catheter-based devices also have the potential to drive increased market penetration in developing markets because of the greater number of trained interventional cardiologists than device implanters"

Here’s a roundup of companies announcing new distribution deals and other joint ventures.

  • CellepathicRx enters agreement with medication adherence company
    Health IT startup CellepathicRx will provide the mobile platform for Adheris’ patient medication adherence program. The deal is worth noting because it’s significant for a young company like Cleveland-based CellepathicRx to receive validation of its technology from a more established company like Adheris, which works with pharmacies to help patients better follow medication instructions. Massachusetts-based Adheris’ pharmacy network includes more than 20,000 pharmacies, which accounts for approximately 45 percent of all retail prescriptions in the U.S., writes MedCity News.
    Read more

  • Pressure BioSciences and KeraFAST ink e-commerce distribution deal
    Pressure BioSciences Inc. (NSDQ:PBIO) and KeraFAST LLC entered into a non-exclusive, worldwide distribution agreement covering several of the company’s new sample preparation products. These products include the recently released The SHREDDER SG3 Extraction System; the novel MicroTube, MicroCap, and PCT Shredder sample processing tubes; and proprietary kits for the preparation of samples for DNA, RNA, protein, and lipid analysis.
    Read more

  • SynapDx licenses Autism diagnostics from Children’s Hospital Boston
    SynapDx Corp. obtained an exclusive world-wide license to technology from Children’s Hospital Boston to accelerate its development of blood-based tests to enable the early detection of Autism Spectrum Disorders. The discoveries were developed through collaboration by Children’s researchers, Dr. Louis Kunkel and Dr. Isaac Kohane. In 2010, SynapDx also obtained rights to blood-based autism detection technologies from George Washington University.
    Read more

  • Lucile Packard Children’s Hospital lands $25 million from HP
    Hewlett-Packard Co. (NYSE:HPQ) announced a planned commitment of $25 million over 10 years to support the projected expansion of Lucile Packard Children’s Hospital at Stanford and a cutting-edge research initiative designed to enhance the safety and quality of care for critically ill patients and their families. HP’s new investment includes support for the expansion of Packard Children’s Hospital, which will add 100 beds to its Palo Alto campus and increase access to state-of-the-art treatments for local children and expectant mothers.
    Read more

  • SeraCare nets another $17 million federal research-support deal
    SeraCare Life Sciences Inc. won a contract renewal, worth about $17.6 million over five years, from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, according to MassHighTech. The Milford, Mass.-based company is provider of products and services that support drug discovery and medical device development.
    Read more

  • Philips and NEC partner on digital pathology
    Royal Philips Electronics (NYSE:PHG) and NEC Corp. (TSE:6701) signed an agreement under which the two companies will jointly develop and market integrated digital pathology solutions. Based around Philips’ new high-throughput pathology slide scanner and NEC’s e-Pathologist Cancer Diagnosis Assistance System, the digital pathology products developed through the contract will be designed to use digital techniques to add quantitative analysis to the qualitative information derived from the visual inspection of pathology slides, which is currently the standard procedure. They will initially be targeted to assist in the grading of breast cancer and prostate cancer.
    Read more

  • MMRGlobal and Alcatel-Lucent partner on personal health record product
    MMRGlobal Inc. (OTC:MMRF) announced that it is working with Alcatel-Lucent to integrate the MyMedicalRecords Personal Health Record with Alcatel-Lucent’s TeleHealth Manager product to simplify the collection and notification of vital health records. Alcatel-Lucent’s TeleHealth Manager is a remote patient monitoring service that leverages the mobile networks of service providers to improve health care.
    Read more

  • ZOLL Medical wins Welsh contract for EMS monitor/defibrillators
    ZOLL Medical Corporation (NSDQ:ZOLL), a manufacturer of medical devices and related software solutions, announced that the Welsh Ambulance Services (WAST) NHS is equipping its frontline ambulances with the ZOLL E Series EMS monitor/defibrillator. Under the terms of the agreement, ZOLL plans to supply a total of 185 E Series units for distribution to the north, central and west, and southeast regions of the Welsh Service.
    Read more

  • Particle Sciences and Celanese team up on drug-eluting device combinations
    Particle Sciences Inc. (PSI), a pharmaceutical CRO, and Celanese EVA Performance Polymers, a supplier of ethylene vinyl acetate (EVA) into pharmaceutical applications, are working together to streamline the development of drug-eluting devices. Building on years of collaboration, Particle Sciences and Celanese EVA Performance Polymers are working to provide Particle Sciences with preferred access to VitalDose EVA polymer in early stage projects.
    Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Contract manufacturers fuel medtech expansion in Costa Rica
    Medical device manufacturing is flourishing in the Central American country, spurred by a host of incentives. This year is seeing a wave of expansions by medtech contract manufacturers in Costa Rica. Medtech OEMs have made the Central American company a manufacturing hub since the 1990s. Major companies operating there include Abbott, Bayer, Boston Scientific, Cardinal… […]
  • Purdue researchers develop biosensor for use during surgery
    Surgeons may soon be able to identify critical regions in tissues and organs during surgery using a biosensor recently developed at Purdue University. The biosensor can be printed in 3D using an automated printing system and allows for simultaneous recording and imaging of tissues and organs during surgery, according to its creator, Chi Hwan Lee.… […]
  • Amcor adds heat seal coating for medtech packaging
    Amcor has introduced a new heat seal coating for medical-grade DuPont Tyvek and paper packaging applications. The Buffalo Grove, Ill.-based company designed this next-generation coating technology to deliver enhanced performance features for healthcare applications. Amcor will produce the new coating, ACT2100, in multiple locations worldwide to offer customers the flexibility to receive supply from the… […]
  • Latest iCad 3D mammography AI gains CE mark
    iCad (NSDQ:ICAD) today announced that the third version of its ProFound AI for digital breast tomosynthesis (DBT) has won CE mark approval. Compared with previous software versions, the latest generation of ProFound AI offers up to a 10% improvement in specificity performance while maintaining a high sensitivity level and approximately 40% faster processing on the… […]
  • Device could reduce chemotherapy-induced pain
    Researchers in Singapore have partnered with Paxman Coolers (U.K.) to develop a device to prevent or reduce numbness and pain caused by chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) is a severe side-effect of chemotherapy drugs called taxanes, which are used to treat common cancers such as breast, lung, ovarian and stomach cancer. CIPN affects about 1.4… […]
  • What medtech’s top executives learned from their dads
    For better or worse, parents including dads play a major role in who we become. With Father’s Day approaching in the U.S., Medical Design & Outsourcing and MassDevice reached out to some of medtech’s top executives to ask what they learned from their dads. Here’s what they said: “My father built a business in the… […]
  • FDA issues docs on medtech remanufacturing, servicing
    The FDA has issued two documents to help distinguish between remanufacturing and servicing of medical devices. One is a draft guidance written to clarify the activities that likely constitute the remanufacturing of a device. The other is a discussion paper on cybersecurity and medtech servicing. The guidance also describes the FDA’s current position on remanufacturing,… […]
  • HelixBind wins $3M grant for sepsis test
    HelixBind announced today it has landed a $3 million federal grant to help develop a test to diagnose bloodstream infections associated with sepsis. The FDA granted Breakthrough Device Designation to the RaPID/BSI test and platform in 2020. Boxborough, Mass.-based HelixBind’s RaPID platform can provide definitive identification and characterization of infections directly from a blood draw… […]
  • Supreme Court upholds Affordable Care Act again
    The U.S. Supreme Court has turned back a third Republican challenge to the Affordable Care Act (ACA), this time by a 7-2 vote. The latest challenge to the law popularly known as Obamacare came from Texas and other states, backed by the administration of former President Donald Trump. The justices ruled that the challengers lacked… […]
  • New monitor could diagnose pregnancy complications
    Researchers at the National Institutes of Health (NIH) have developed a prototype device that could potentially diagnose pregnancy complications by monitoring the oxygen level of the placenta. The device sends near-infrared light through the abdomen to measure oxygen levels in the arterial and venous network in the placenta. The method was used to study the… […]
  • Dabir Surfaces forges deal with Vizient
    Dabir Surfaces (Harwood Heights, Ill.) recently announced that it has landed a contract with group purchasing firm Vizient. Dabir also announced a deal with Premier this month.  The contract with Vizient, effective April 1, 2021, involves both OR products and patient care products. Dabir will provide powered overlay surfaces for patients at risk of developing pressure… […]

Leave a Reply